Evidence map›Paper›PMID 35914102›Full record

ArticleJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research2022

CWHM-12, an Antagonist of Integrin-Mediated Transforming Growth Factor-Beta Activation Confers Protection During Early

Ninecia R Scott, Shyamala Thirunavukkarasu, Javier Rangel-Moreno, David W Griggs, Shabaana A Khader

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ninecia R ScottDepartment of Molecular Microbiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Shyamala ThirunavukkarasuDepartment of Molecular Microbiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.ORCID 0000-0001-9888-3304
Javier Rangel-MorenoDivision of Allergy, Immunology and Rheumatology, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA.
David W GriggsDepartment of Molecular Microbiology & Immunology, Saint Louis University School of Medicine, St. Louis, Missouri, USA.
Shabaana A KhaderDepartment of Molecular Microbiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Washington University in St. Louis · USSaint Louis University · USUniversity of Rochester Medical Center · US

Funding

Viral Testing CoreU42OD010442 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Deepak Kaushal, Kathryn Shelton · 2012 to 2026
$35.6M
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosisR01AI155024 · NIAID · WASHINGTON UNIVERSITY · PI KAUSHAL, DEEPAK, KHADER, SHABAANA A. · 2020 to 2024
$4.1M
NIH HHS U42 OD010442
6 · The paper itself

Abstract

Tuberculosis (TB) caused by the pathogenic bacterium

Indexed as

Mycobacterium tuberculosisTuberculosisAnimalsIntegrinsMiceTransforming Growth Factor betaTransforming Growth FactorsIntegrinsTransforming Growth Factor betaTransforming Growth FactorscollagenCWHM-12fibrosisinflammationintegrinsmacrophagesMycobacterium tuberculosisneutrophilsTGF-β

Identifiers

PMID35914102
PMCPMC9422778
OpenAlexW4289262347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.